Clincosm LogoSign in Get a demo

newly diagnosed

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • +2 more
  • Ponatinib 15 MG Oral Tablet
  • Brno, Czechia
  • +6 more
Nov 30, 2022

Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

Recruiting
  • Acute Monocytic Leukemia
  • Newly Diagnosed
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 3, 2022

Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute, Adult
  • +2 more
  • Brno, Czechia
  • +4 more
Aug 3, 2022

Patient and Healthcare Provider Satisfaction of Daratumumab Use

Recruiting
  • Multiple Myeloma
  • +5 more
  • Daratumumab
  • Frankfurt, Hessen, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Aug 1, 2022

Breast Cancer, Non-metastatic, Newly Diagnosed Trial in Grenoble, Saint-Martin-d'Hères (alternative medicine education

Not yet recruiting
  • Breast Cancer
  • +3 more
  • alternative medicine education consultation
  • Grenoble, France
  • +1 more
Jul 12, 2022

Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Newly Diagnosed Trial in Tianjin (Zanubrutinib, Fludarabine,

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Zanubrutinib, Fludarabine, cyclophosphamide and rituximab
  • Zanubrutinib, bendamustine, rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 18, 2022

Identify Barriers to Allogeneic Hematopoietic Stem Cell

Recruiting
  • Acute Leukemia
  • +2 more
  • assessments
  • Hartford, Connecticut
  • +2 more
Jan 21, 2022

Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer Trial in Worldwide (Rucaparib, Nivolumab, Placebo Oral

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +6 more
  • Phoenix, Arizona
  • +238 more
Nov 3, 2021

Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cladribine Injection
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)

Unknown status
  • Myeloma
  • +2 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

Imatinib: Development of Late Side Effects and Compliance to

Completed
  • Chronic Myeloid Leukemia
  • Newly Diagnosed
  • London, United Kingdom
    Haematology Department. Catherine Lewis Centre. Hammersmith Hosp
Jul 3, 2019

Diabetes, Type 2, Newly Diagnosed Trial in China (exenatide injection, Mixed Protamine Zinc Recombinant Human Insulin Lispro

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Newly Diagnosed
  • exenatide injection
  • +2 more
  • Beijing, Beijing, China
  • +24 more
Jun 11, 2013